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ABSTRACT 
 
Cases of twin pregnancy where a normal viable fetus coexists with a hydatidiform mole have been reported rarely. 
The incidence ranges from 1 in 20,000 to 1 in 1, 00000 pregnancies. This condition is a consequence of dizygotic 
twinning. The fetus, in such cases, is chromosomally normal as opposed to the mole. We report one such case where 
a twin pregnancy consisted of a viable 12 week old fetus and its normally formed placenta coexisting with a 
complete hydatidiform mole in the other twin sac. There is a greater risk of persistent trophoblastic disease (50–
60%) in cases where a complete mole coexists with a fetus as opposed to single molar pregnancies (14%).By 
reporting this case, we strive to highlight the need for more vigilant obstetric surveillance in such patients by serial 
beta-HCG estimation, and sonographic evaluation in conjunction with doppler and MRI when available. 
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Case Report 
 
A 25 year-old primigravida with 12 weeks gestation 
reported to the emergency room with complaints of 
pain abdomen, recurrent vaginal bleeding, headache 
and palpitations. She gave a history of episodes of 
slight vaginal bleeding in the past. A general physical 
exam was unremarkable. Abdominal palpation 
revealed a fundal height corresponding to 18 weeks 
(large for gestational age). A separate mass was 
palpable on the left side of the uterus. Upon 
auscultation normal foetal heartbeats could be heard on 
the right side. A sonographic evaluation of the 
abdomen revealed a viable and structurally normal 12 
week old fetus and placenta in the right side of the 
uterine cavity. The placenta was normally formed, 
posteriorly located and showed grade I maturity. A 
concurrent mass could be seen in the left side of the 
uterine cavity, with characteristic snow storm 
appearance and multiple small cystic spaces within the 
mass. This sonographic morphology was consistent 
with a complete hydatidiform molar pregnancy (Figure 
1). A subchorionic hematoma, separate from the 
placenta, was also observed in the region of the mole. 
Both the ovaries were normal, with no evidence of 
theca lutein cysts. Serum titre of beta-hCG at 12 weeks 
was130000 mIU/ml.  
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X-ray chest and liver function tests were normal. The 
serum levels of thyroid hormones were mildly raised. 
The prognosis and possible obstetric outcome were 
explained. The patient was advised admission to the 
inpatient department and kept under observation. An 
MRI scan confirmed the sonographic findings, with no 
obvious invasion of the myometrium and the zone of 
transition between mole and the myometrium showing 
clearer delineation (Figure 2). The subsequent clinical 
course of the patient consisted of gradually worsening 
symptoms with increased bouts of dirty vaginal 
discharge and characteristic grape like vesicles. The 
patient underwent spontaneous abortion at13 weeks of 
gestation with expulsion of the hydatidiform mole. The 
patient delivered a foetus two days after the expulsion 
of the mole. Suction and curettage was later performed 
to remove any retained products of conception. The 
histopathology of the abnormal posterior placenta 
revealed grapelike, vacuolar degeneration of chorionic 
villi and abnormal, excessive proliferation of placental 
trophoblasts. Karyotyping of the baby’s white cells and 
mole revealed normal 46-XX chromosomal patterns. 
Mother’s chest radiograph, abdominopelvic 
sonography and serum beta HCG marker study done 
postpartum did not reveal any abnormality. No 
chemotherapy was given. However, she was kept under 
observation and asked to report after 3 months. The 
need for obstetric surveillance was explained to the 
patient. 
 
Discussion 
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Twin pregnancies with a molar pregnancy and a co-
existing viable fetus have been described .The cases 
with gestational trophoblastic disease concurrent with 
normal intrauterine pregnancy have been reported as 
rarely as one in 20,000-1, 00,000 pregnancies 3 and in 
2.5 to 5 percent of molar pregnancies [1, 2].Gestational 
trophoblastic disease (GTD) includes a spectrum of 
disorders characterized by abnormal proliferation of 
trophoblasts with progressive malignant potential. 
GTD includes molar pregnancy, invasive mole, 
choriocarcinoma and placental site trophoblastic 
neoplasia with varying degrees of malignant 
potential.Hydatidiform mole constitutes 80% of cases 
of GTD and includes complete hydatidiform mole (also 
called classic hydatidiform mole) and partial 
hydatidiform mole. A „complete mole‟ represents total 
replacement of the normal placenta by grossly dilated, 
hydropic villi. It is usually not associated with foetus or 
foetal parts, except with a coexisting twin pregnancy. 
When an empty ovum is fertilized by single sperm with 
duplication of the paternal haploid set of chromosomes 
a46-XX karyotype is produced (46-YY is lethal).A 
„partial mole‟ contains molar tissue along with 
abnormal fetal parts.When a normal haploid ovum is 
fertilised by two haploid sperms a „partial mole‟ is 
formed. This contains a triploid karyotype (69 
chromosomes) [3]. In case of a partial mole foetal parts 
are almost always present but are abnormal. The 
pregnancy doesnot usually last beyond the first 
trimester. The majority of cases of pregnancies of 
hydatidiform mole with a coexistent live fetus 
diagnosed antenatally by ultrasound examination can 
be categorized either as a “twin gestation”, in which it 
is postulated that one gestation develops normally with 
a normal karyotype while the second undergoes 
complete molar degeneration or as a “partial mole”, 
described as conceptus with an abnormal fetus and a 
single placenta manifesting diffuse hydatidiform 
changes. Both partial and complete moles are 
noninvasive aberrations that demonstrate both 
proliferation and hydropic swelling of the villi. 
Histologic analysis shows the villi to have a prominent, 
central a cellular space, which accounts for the 
macroscopic appearance of fluid-filled vesicles. 
Microscopic evaluation shows trophoblastic 
hyperplasia which accounts for the characteristic 
marked elevation of beta-hCG levels, which may lead 
to hyperemesis or development of the calutein cysts. 
Serum beta-HCG levels in molar pregnancy are 
abnormally elevated, commonly over 1,00,000 
mIU/ml.Patients with molar pregnancy most 
commonly present with vaginal bleeding, rapid uterine 
enlargement, large for date uterus, hyperemesis 
gravidarum or preeclampsia before 24 weeks. If a 
foetus is identified in this syndrome it is rarely alive at 
the time of diagnosis, and generally manifests a 
constellation of congenital anomalies associated with 
triploidy. In the twin gestational syndrome the fetus 
will have normal diploid chromosomal karyotype as 
the condition is usually the result of dizygotic 
twinning. When the diagnosis has been made 
antenatally,most patients have opted for termination of 
the pregnancy to avoid the risks of malignant change 
and complications such as pre-eclampsia and 
antepartum hemorrhage [1].Sonography is the initial 
modality of choice in the diagnosis [4, 5]. The 
sonographic appearance of hydatidiform mole has been 
characteristically described as “snow storm 
appearance“. Numerous discrete, small, anechoic 
(cystic) spaces within a central area of heterogeneous 
echotexture may be identified within the uterus. The 
small cystic areas correspond to the hydropic villi 
characteristically seen at gross pathologic examination. 
A complete hydatidiform mole (CHM) may have 
variable appearances in the first trimester [6]. A large, 
central fluid collection that mimics and an embryonic 
gestation or missed/incomplete abortion may be seen. 
Occasionally, there is merely a central mass of variable 
echogenicity, presumably because the villi are too 
small to be detected by sonography at this time. Molar 
tissue has been seen to have a characteristic appearance 
on MRI. The molar tissue appears hyperintense on 
theT2 W images [7]. The myometrium is clearly shown 
as a separate structure and this allows accurate 
assessment of invasion. MRI findings may include: a) 
heterogeneous endometrial enlargement with several 
hyperintense foci that represent hydropic villi on T2-
weighted imaging; b) focal tumoral masses in the 
endometrium and/or myometrium; c) loss of uterine 
zonal anatomy(indistinctness of the endometrial-
myometrial border); and d) pathologic myometrial, 
endometrial, and parametrial vasculature characterized 
by dilated and tortuous vessels [8, 9, 10].Importantly, 
15% of women with complete hydatidiform mole and 
less than 1% of patients with partial hydatidiform mole 
will develop recurrent disease in the form of invasive 
mole or choriocarcinoma. Recent reviews indicate that 
there is a greater risk of developing persistent 
trophoblastic disease (50–60%) in cases of CHM and a 
co-existing fetus compared with a single molar 
pregnancy (14%) and that when present, it more 
commonly progresses to metastatic disease [1]. To date 
no significant mortality has been reported as most of 
these cases have been terminated estrogenically or 
aborted spontaneously [11]. All patients need to be 
followed up with successive serum beta-HCG 
measurements to allow early detection of persistent 
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gestational trophoblastic neoplasia (i.e., invasive mole 
or choriocarcinoma). Serial monitoring of beta-HCG 
levels during the first year after treatment of complete 
hydatidiform mole is thus, very important. Pregnancy 
should therefore be avoided during this time as it 
causes raised beta-hCG levels [6].Patients with 
invasive mole present with bleeding per vaginum and 
persistent elevations in the serum beta-hCG level. 
Imaging may show a central uterine process similar to 
that described for complete hydatidiform mole, 
occasionally with demonstrable myometrial invasion. 
For obstetric surveillance ultrasound proves to be an 
important diagnostic tool, and several predictors for 
suspicion of invasive changes have been put forward 
[11]. The important ones are the presence of 
endometrial thickening (>10 mm) with hyper 
vascularisation upon TV-US (trans-vaginal 
ultrasonography), or myometrial nodules 
(hyperechogenic areas of increased vascularization 
within the myometrium). Doppler US may be useful in 
the evaluation of GTD. These vascular tumors tend to 
show very high blood flow (more specifically, high 
diastolic flow). Presumably the result of decreased 
vessel tone in the proliferating neoplasm has been 
identified in patients with persistent gestational 
trophoblastic neoplasia. A decrease in uterine artery 
pulsatility maybe of some use in the diagnosis of cases 
that may mimic other conditions (e.g., threatened 
abortion or uterine atony). The persistently elevated 
beta-HCG level will usually indicate the diagnosis. 
 
 
 
 
Figure 1:Evidence of complete hydatidiform mole along the left side of the uterus with a coexistent twin live 
gestation and its separate normal placenta along the right side of the hydatidiform mole 
 
 
 
Figure 2: T2W coronal MRI shows similar changes as sonography with the molar tissue appearing 
hyperintense on the left (double white arrows) and a coexistent twin gestation with normally formed posterior 
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placenta along the right. A focal area of subchrorionic bleeds (single white arrow) complicating the 
hydatidiform mole is appreciated well on this MRI. 
 
Conclusion 
 
The coexistence of a twin pregnancy with a viable fetus 
in one sac and mole affecting the other twin is a very 
rare incidence. The obstetric outcome usually 
culminates in spontaneous abortion/ iatrogenic 
termination due to the inherent complications of the 
mole. Also there is a greater risk of recurrent/persistent 
gestational neoplasia in a coexistent twin pregnancy 
with an associated mole. Strict guidelines, therefore, 
need to be laid in such cases for obstetric vigilance. 
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